Unlikely association of nephrectomy post-mRCC with anti-VEGF-induced renal TMA

por Izzedine, Hassane, Massard, Christophe, Soria, Jean Charles
Publicado 2011

ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer

por Fizazi, Karim, Albiges, Laurence, Loriot, Yohann, Massard, Christophe
Publicado 2015

Durvalumab for the management of urothelial carcinoma: a short review on the emerging data and therapeutic potential

por Baldini, Capucine, Champiat, Stéphane, Vuagnat, Perrine, Massard, Christophe
Publicado 2019

Coronavirus disease (COVID-19) outbreak and phase 1 trials: should we consider a specific patient management?

por Postel-Vinay, Sophie, Massard, Christophe, Soria, Jean-Charles
Publicado 2020

Meta-analysis and Critical Review: Association Between Radio-induced Lymphopenia and Overall Survival in Solid Cancers

por El Houat, Yasmine, Massard, Christophe, Quillien, Veronique, de Crevoisier, Renaud, Castelli, Joël
Publicado 2022

Photoactive TiO(2) antibacterial coating on surgical external fixation pins for clinical application

por Villatte, Guillaume, Massard, Christophe, Descamps, Stéphane, Sibaud, Yves, Forestier, Christiane, Awitor, Komla-Oscar
Publicado 2015

Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer

por Delaye, Matthieu, Rousseau, Adrien, Try, Mélanie, Massard, Christophe, Campedel, Luca, Hilmi, Marc, Bagnis, Corinne
Publicado 2022

Notch inhibitors induce diarrhea, hypercrinia and secretory cell metaplasia in the human colon

por Collins, Michael, Michot, Jean-Marie, Bellanger, Christophe, Mussini, Charlotte, Benhadji, Karim, Massard, Christophe, Carbonnel, Franck
Publicado 2021

Case Report: Expanding the tumour spectrum associated with the Birt-Hogg-Dubé cancer susceptibility syndrome

por Benusiglio, Patrick R., Gad, Sophie, Massard, Christophe, Carton, Edith, Longchampt, Elisabeth, Faudot, Tiffany, Lamoril, Jérôme, Ferlicot, Sophie
Publicado 2014

Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients

por Cabel, Luc, Loir, Elika, Gravis, Gwenaelle, Lavaud, Pernelle, Massard, Christophe, Albiges, Laurence, Baciarello, Giulia, Loriot, Yohann, Fizazi, Karim
Publicado 2017

Impact of COVID-19 Pandemic on Cancer Research

por Zon, Leonard, Gomes, Ana P., Cance, William G., Ribas, Antoni, Tuveson, David, Postel-Vinay, Sophie, Massard, Christophe, Barlési, Fabrice
Publicado 2020

Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death

por Le Scodan, Romuald, Jouanneau, Ludivine, Massard, Christophe, Gutierrez, Maya, Kirova, Youlia, Cherel, Pascal, Gachet, Julie, Labib, Alain, Mouret-Fourme, Emmanuelle
Publicado 2011

Therapeutic potential of the human endogenous retroviral envelope protein HEMO: a pan‐cancer analysis

por Kasperek, Amélie, Béguin, Anthony, Bawa, Olivia, De Azevedo, Kévin, Job, Bastien, Massard, Christophe, Scoazec, Jean‐Yves, Heidmann, Thierry, Heidmann, Odile
Publicado 2021

A Case-Control Study Brings to Light the Causes of Screen Failures in Phase 1 Cancer Clinical Trials

por Kempf, Emmanuelle, Lemoine, Nathalie, Tergemina-Clain, Gabrielle, Turpin, Anthony, Postel-Vinay, Sophie, Lanoy, Emilie, Soria, Jean-Charles, Massard, Christophe, Hollebecque, Antoine
Publicado 2016

Patient-reported tolerability of adverse events in phase 1 trials

por Henon, Clémence, Lissa, Delphine, Paoletti, Xavier, Thibault, Constance, Le Tourneau, Christophe, Lanoy, Emilie, Hollebecque, Antoine, Massard, Christophe, Soria, Jean-Charles, Postel-Vinay, Sophie
Publicado 2017

Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influence

por Dercle, Laurent, Ammari, Samy, Bateson, Mathilde, Durand, Paul Blanc, Haspinger, Eva, Massard, Christophe, Jaudet, Cyril, Varga, Andrea, Deutsch, Eric, Soria, Jean-Charles, Ferté, Charles
Publicado 2017

Phase I study of afatinib combined with nintedanib in patients with advanced solid tumours

por Bahleda, Rastislav, Hollebecque, Antoine, Varga, Andrea, Gazzah, Anas, Massard, Christophe, Deutsch, Eric, Amellal, Nadia, Farace, Françoise, Ould-Kaci, Mahmoud, Roux, Flavien, Marzin, Kristell, Soria, Jean-Charles
Publicado 2015

Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines?

por Watson, Sarah, Menis, Jessica, Baldini, Capucine, Martin-Romano, Patricia, Michot, Jean-Marie, Hollebecque, Antoine, Armand, Jean-Pierre, Massard, Christophe, Soria, Jean-Charles, Postel-Vinay, Sophie, Paoletti, Xavier
Publicado 2018

Case Report: Response to Immunotherapy, Can Radiotherapy Be a Troublemaker?

por Martin-Romano, Patricia, Adam, Julien, Scoazec, Jean-Yves, Gouy, Sébastien, Levy, Antonin, Baldini, Capucine, Champiat, Stéphane, Soria, Jean-Charles, Massard, Christophe, Marabelle, Aurélien, Deutsch, Eric, Hollebecque, Antoine
Publicado 2021

Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castrationresistant prostate cancer: a report from the PETRUS prospecti...

por Massard, Christophe, Oulhen, Marianne, Le Moulec, Sylvestre, Auger, Nathalie, Foulon, Stéphanie, Abou-Lovergne, Aurélie, Billiot, Fanny, Valent, Alexander, Marty, Virginie, Loriot, Yohann, Fizazi, Karim, Vielh, Philippe, Farace, Francoise
Publicado 2016